证券日报网讯12月18日，海泰科（301022）在互动平台回答投资者提问时表示，公司改性塑料已应用于 部分电子电器类产品的结构件、功能件，鉴于商业保密原则，公司不便透露与客户合作的具体信息。 ...

Group 1 - The core viewpoint of the article is that Hitec (301022.SZ) has stated that its modified plastic products currently do not have applications in the aviation sector [1] Group 2 - The company communicated this information through an investor interaction platform [1]

Core Viewpoint - The company Haitai Technology (301022.SZ) has announced a delay in the expected operational date of its high polymer new materials project from January 31, 2026, to January 31, 2028, due to adjustments in construction progress and market conditions [1] Group 1: Project Details - The project aims to achieve an annual production capacity of 150,000 tons of high polymer new materials [1] - As of November 30, 2025, the company has invested 122.0528 million yuan, which accounts for 31.19% of the planned total investment [1] - There remains 269.3228 million yuan of unutilized raised funds, which will continue to be used for project construction [1] Group 2: Reasons for Delay - The primary reason for the delay is to maintain the advanced nature of production equipment and processes, avoiding short-term overcapacity [1] - The company has decided to prudently adjust the investment pace, which involves a reduction in the implementation subject and location in Qingdao, Shandong Province, focusing resources on the construction of the production base in Shou County, Huainan City, Anhui Province [1]

证券日报网讯 12月17日，海泰科发布公告称，公司第三届董事会第五次会议审议通过《关于减少募投 项目实施主体、实施地点及延期的议案》《关于与关联方共同向参股子公司增资暨关联交易的议案》 《关于2026年度日常关联交易预计的议案》等多项议案。 （文章来源：证券日报） ...

Group 1 - CICC is planning to absorb and merge Dongxing Securities and Xinda Securities through a share swap, with trading resuming on December 18, 2025 [1] - Victory Energy's major shareholder plans to transfer 29.99% of its shares to Qiteng Robotics, with no plans for asset restructuring in the next 12 months [2] - China Metallurgical Group intends to repurchase A-shares worth 1 to 2 billion yuan at a price not exceeding 4.9 yuan per share [3] Group 2 - Boten Co. plans to acquire part of the Yifeng Yunding Fund for 1 yuan, with a commitment to fulfill a 20 million yuan capital contribution [4] - Tongyou Technology has initiated a 50 million yuan accounts receivable factoring business [5] - Gaode Infrared has received approval to issue debt financing tools totaling up to 3 billion yuan [6] Group 3 - Zhengyu Industrial's application for a private placement of A-shares has been approved by the Shanghai Stock Exchange [7] - China CRRC signed contracts totaling approximately 53.31 billion yuan, accounting for 21.6% of its projected 2024 revenue [9] - High Energy Environment's director increased his stake by purchasing 56,100 shares [10] Group 4 - Shantou Technology received approval from the CSRC for a convertible bond issuance [11] - Puyang Co. plans to use up to 900 million yuan of idle funds for entrusted wealth management [12] - Huibai New Materials has been awarded a government subsidy of 3.8 million yuan, with the first installment of 2.12 million yuan already received [13] Group 5 - Jiayuan Technology's shareholders plan to transfer 2.51% of the company's shares through a pricing inquiry [14] - Lingpai Technology's subsidiary terminated a 125 million yuan procurement contract due to market changes [15] - Juguang Technology intends to use up to 200 million yuan of idle funds for cash management [16] Group 6 - Zhongwen Media's subsidiary terminated a 200 million yuan private equity fund subscription due to market changes [17] - Zhifei Biological's modified vaccine for monkeypox has received clinical trial acceptance [19] - GeKowei's subsidiary received a government subsidy of 60 million yuan, accounting for 32.12% of the company's audited net profit [20] Group 7 - Wantai Biological's application for a clinical trial of a respiratory syncytial virus vaccine has been accepted [21] - Haitai Technology plans to increase capital in its Thai joint venture from 500,000 to 3 million Thai baht [22] - Shanghai Airport signed contracts for the transfer of duty-free store operating rights [23] Group 8 - Del Shares received approval to issue shares for the acquisition of 100% of Aizhuo Intelligent [24] - Novozymes' products have obtained EU CE IVDR certification [25] - Shibai Testing's chairman's assistant plans to increase shareholding by 8 to 12 million yuan [26] Group 9 - Huitian New Materials plans to invest approximately 97.68 million yuan in a lithium battery anode glue project [27] - Pudong Construction's subsidiaries won contracts totaling 1.649 billion yuan [29] - Acolyte's subsidiary has entered trial production for a special high-temperature resistant resin project [30] Group 10 - Pingzhi Information's subsidiary signed a 38.25 million yuan computing power service contract [31] - Tianma Technology is required to pay 5.3625 million yuan in taxes and penalties [32] - Yahon Pharmaceutical's clinical trial application for GLX002 has been approved [34]

为增强合资公司实力，公司与新材料工业园拟签署《增资协议》，将合资公司的投资额由人民币500.00 万元增加至人民币660.00万元，并将合资公司的注册资本由500.00万泰铢增加至3,000.00万泰铢（具体金 额以泰国当地行政主管部门审批为准）。 格隆汇12月17日丨海泰科(301022.SZ)公布，公司于2025年5月经总经理办公会会议审批，同意由全资子 公司海泰科模塑（泰国）有限公司（简称"海泰科（泰国）"）以自有资金与青岛新材料科技工业园发展 有限公司（简称"新材料工业园"）在泰国共同投资设立海泰科新材料泰国有限公司（简称"合资公 司"），合资公司总投资额为人民币500.00万元，其中新材料工业园出资人民币255.00万元，持股 51.00%，海泰科（泰国）出资人民币245.00万元，持股49.00%。合资公司已于2025年5月29日取得泰国 当地行政主管部门颁发的注册文件。 ...

海泰科公告，公司全资子公司海泰科模塑（泰国）有限公司与关联方青岛 新材料科技工业园发展有限 公司在泰国共同投资设立的合资公司海泰科新材料泰国有限公司，原注册资本为500万泰铢。现计划将 合资公司注册资本增加至3000万泰铢，总投资额增加至660万元人民币。新材料工业园出资336.6万元人 民币，持股51.00%；海泰科（泰国）出资323.4万元人民币，持股49.00%。本次交易构成关联交易，需 提交公司董事会审议。 ...

国泰海通证券股份有限公司 关于青岛海泰科模塑科技股份有限公司 减少募投项目实施主体、实施地点及延期的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐人"）作为青 岛海泰科模塑科技股份有限公司（以下简称"海泰科"或"公司"）向不特定对 象发行可转换公司债券的保荐人，根据《证券发行上市保荐业务管理办法》《深 圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》《上市公司募集资金监管规则》等有关法律、法规、规范性 文件的规定，对公司减少募投项目实施主体、实施地点及延期的事项进行了核查， 具体情况如下： 一、募集资金基本情况 公司募集资金已于 2023 年 7 月 3 日到账，并经中兴华会计师事务所（特殊 普通合伙）进行了审验，出具了《验资报告》（中兴华验字（2023）第 030019 号）。 公司已按规定对募集资金进行了专户存储，并与保荐人、存放募集资金的银行签 署了募集资金三方监管协议。 二、募投项目基本情况 根据《青岛海泰科模塑科技股份有限公司向不特定对象发行可转换公司债券 募集说 ...

证券代码：301022 证券简称：海泰科 公告编号：2025-186 青岛海泰科模塑科技股份有限公司 关于 2026 年度日常关联交易预计的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、日常关联交易基本情况 （一）日常关联交易概述 根据青岛海泰科模塑科技股份有限公司（以下简称"公司"）及全资子公司实际 经营发展的需要，对 2026 年度日常关联交易进行了合理的预计，预计 2026 年公司及 全资子公司拟与关联方青岛新材料科技工业园发展有限公司（以下简称"新材料工业 园"）及其控股子公司发生总金额不超过人民币 334.00 万元（含税）的日常关联交易。 （二）日常关联交易履行的审议程序 公司于 2025 年 12 月 17 日召开第三届董事会第五次会议，以 8 票同意、0 票反对、 0 票弃权、0 票回避的表决结果审议通过了《关于 2026 年度日常关联交易预计的议案》。 本次预计发生关联交易的关联方与公司现任董事不存在关联关系，无需回避表决。本 事项已经公司第三届董事会第一次独立董事专门会议审议通过，全体独立董事一致同 意该议案，并同意将该议案提交 ...

国泰海通证券股份有限公司 关于青岛海泰科模塑科技股份有限公司 （一）日常关联交易概述 根据青岛海泰科模塑科技股份有限公司（以下简称"公司"）及全资子公司 实际经营发展的需要，对 2026 年度日常关联交易进行了合理的预计，预计 2026 年公司及全资子公司拟与关联方青岛新材料科技工业园发展有限公司（以下简称 "新材料工业园"）及其控股子公司发生总金额不超过人民币 334.00 万元（含税） 的日常关联交易。 （二）日常关联交易履行的审议程序 公司于 2025 年 12 月 17 日召开第三届董事会第五次会议，以 8 票同意、0 票反对、0 票弃权、0 票回避的表决结果审议通过了《关于 2026 年度日常关联交 易预计的议案》。本次预计发生关联交易的关联方与公司现任董事不存在关联关 系，无需回避表决。本事项已经公司第三届董事会第一次独立董事专门会议审议 通过，全体独立董事一致同意该议案，并同意将该议案提交董事会审议。保荐人 对本次 2026 年度日常关联交易预计事项出具了无异议的核查意见。本次预计关 联交易金额在董事会的审批权限范围内，无需提交公司股东会审议。 1 （三）预计日常关联交易类别和金额 | | | ...